EG240327 Inhibitors
EG240327 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the **EG240327** protein or molecule, which is likely involved in various biological processes such as enzymatic regulation, signal transduction, or molecular transport. These inhibitors work by binding to EG240327 and preventing it from performing its natural function within the cell. The disruption of EG240327's activity through inhibition provides researchers with an opportunity to study its role in cellular metabolism, molecular signaling, or other crucial pathways. By blocking its normal function, scientists can observe how the inhibition of EG240327 affects the broader biochemical network and how it alters key cellular functions such as protein synthesis, energy balance, or molecular transport.
The study of EG240327 inhibitors also reveals how this molecule interacts with other proteins or molecules within the cell, contributing to a deeper understanding of its regulatory mechanisms. Inhibiting EG240327 allows researchers to identify the downstream effects of its absence and to determine how its inhibition influences other cellular components and processes. Through these studies, scientists can better understand the intricate connections between EG240327 and its associated pathways, uncovering the molecular feedback loops that maintain cellular homeostasis. Overall, EG240327 inhibitors serve as important tools for elucidating the biological significance of this molecule and its interactions, helping to reveal how cells adapt to changes in molecular function and how these interactions contribute to maintaining cellular and biochemical stability.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Inhibits Iigp1c indirectly by blocking lysosomal acidification, disrupting autophagy. The disturbance in autophagy impacts cellular response to interferon-beta and inhibits Iigp1c's function in the endoplasmic reticulum membrane. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor affecting autophagy and interferon-beta signaling. By inhibiting mTOR, Rapamycin indirectly modulates Iigp1c activity, disrupting its role in the endoplasmic reticulum membrane and cellular response to interferon-beta. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $290.00 | 7 | |
Blocks ion channels, impacting interferon-beta-induced responses. Amiloride indirectly inhibits Iigp1c by disrupting cellular response to interferon-beta, altering its activity in the endoplasmic reticulum membrane. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Calcium ionophore affecting interferon-beta signaling. A23187 indirectly inhibits Iigp1c by influencing calcium-dependent processes, disrupting cellular response to interferon-beta and altering Iigp1c's activity in the endoplasmic reticulum membrane. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor impacting interferon-beta signaling. SB203580 indirectly inhibits Iigp1c by modulating p38 MAPK, disrupting interferon-beta responses and altering Iigp1c's function in the endoplasmic reticulum membrane. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor affecting interferon-beta responses. Wortmannin indirectly inhibits Iigp1c by disrupting the PI3K/AKT pathway, altering interferon-beta signaling and Iigp1c's function in the endoplasmic reticulum membrane. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Inhibits Iigp1c indirectly by blocking autophagy and altering interferon-beta responses. Chloroquine disrupts cellular response to interferon-beta, impacting Iigp1c function in the endoplasmic reticulum membrane. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits sarco/endoplasmic reticulum Ca2+-ATPases (SERCA), indirectly influencing Iigp1c. Thapsigargin disrupts calcium homeostasis, altering interferon-beta responses and Iigp1c's activity in the endoplasmic reticulum membrane. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $57.00 $200.00 | 15 | |
DNA synthesis inhibitor affecting interferon-beta responses. Fludarabine indirectly inhibits Iigp1c by disrupting DNA synthesis, altering interferon-beta signaling and Iigp1c's function in the endoplasmic reticulum membrane. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor influencing interferon-beta signaling. SP600125 indirectly inhibits Iigp1c by modulating JNK, disrupting interferon-beta responses and altering Iigp1c's function in the endoplasmic reticulum membrane. | ||||||